Prothrombotic autoantibodies targeting platelet factor 4/polyanion are associated with pediatric cerebral malaria

Vera, IM; Kessler, A; Harawa, V; Ahmadu, A; Keller, TE; Ray, STJ; Taylor, TE; Rogerson, SJ; Mandala, WL; Reyes Gil, M; Seydel, KB; Kim, K

Journal article

Prothrombotic autoantibodies targeting platelet factor 4/polyanion are associated with pediatric cerebral malaria

Abstract:: Background: Features of consumptive coagulopathy and thromboinflammation are prominent in cerebral malaria (CM). We hypothesized that thrombogenic autoantibodies contribute to a procoagulant state in CM.

Methods: Plasma from children with uncomplicated malaria (UM) (n = 124) and CM (n = 136) was analyzed by ELISA for a panel of 8 autoantibodies including anti–platelet factor 4/polyanion (anti-PF4/P), anti-phospholipid, anti-phosphatidylserine, anti-myeloperoxidase, anti–proteinase 3, anti-dsDNA, anti–β-2-glycoprotein I, and anti-cardiolipin. Plasma samples from individuals with nonmalarial coma (NMC) (n = 49) and healthy controls (HCs) (n = 56) were assayed for comparison. Associations with clinical and immune biomarkers were determined using univariate and logistic regression analyses.

Results: Median anti-PF4/P and anti–PS IgG levels were elevated in individuals with malaria infection relative to levels in HCs (P < 0.001) and patients with NMC (PF4/P: P < 0.001). Anti–PF4/P IgG levels were elevated in children with CM (median = 0.27, IQR: 0.19-0.41) compared with those with UM (median = 0.19, IQR: 0.14–0.22, P < 0.0001). Anti–PS IgG levels did not differ between patients with UM and those with CM (P = 0.39). When patients with CM were stratified by malaria retinopathy (Ret) status, the levels of anti–PF4/P IgG correlated negatively with the peripheral platelet count in patients with Ret⁺ CM (Spearman’s rho [R_s] = 0.201, P = 0.04) and associated positively with mortality (OR = 15.2, 95% CI: 1.02–275, P = 0.048). Plasma from patients with CM induced greater platelet activation in an ex vivo assay relative to plasma from patients with UM (P = 0.02), and the observed platelet activation was associated with anti–PF4/P IgG levels (R_s= 0.293, P = 0.035).

Conclusions: Thrombosis mediated by elevated anti-PF4/P autoantibodies may be one mechanism contributing to the clinical complications of CM.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Vera, I. M., Kessler, A., Harawa, V., Ahmadu, A., Keller, T. E., Ray, S. T. J., Taylor, T. E., Rogerson, S. J., Mandala, W. L., Reyes Gil, M., Seydel, K. B., & Kim, K. (2024). Prothrombotic autoantibodies targeting platelet factor 4/polyanion are associated with pediatric cerebral malaria. Journal of Clinical Investigation, 134(11).

MLA Style

Vera, IM, et al. “Prothrombotic Autoantibodies Targeting Platelet Factor 4/Polyanion Are Associated with Pediatric Cerebral Malaria.” Journal of Clinical Investigation, vol. 134, no. 11, 2024.

Chicago Style

Vera, IM, A Kessler, V Harawa, et al. 2024. “Prothrombotic Autoantibodies Targeting Platelet Factor 4/Polyanion Are Associated with Pediatric Cerebral Malaria.” Journal of Clinical Investigation 134 (11).
Print